by Josh Nightingale | Jan 4, 2024 | 325(d) issues, Trial Institution
By Connor Scholes, Ashvi Patel, and Josh Nightingale – On November 6, 2023, the PTAB issued an decision instituting inter partes review of U.S. Patent No. 10,681,009 B2 (“the ’009 patent”) in Keysight Technologies, Inc. v. Centripetal Networks, Inc.,...
by Matthew Johnson | Dec 22, 2023 | Prior Art Issues, PTAB News, Trial Institution
By Hannah Mehrle and Matt Johnson – In IPR2023-01058, the PTAB declined to institute IPR, finding that Patent Owner had disclaimed all challenged claims under 35 U.S.C. § 243(a), in compliance with 37 C.F.R. § 1.321(a), such that there was no basis on which to...
by Carl Kukkonen | Dec 14, 2023 | PTAB News, PTAB Trial Basics, Request for Reconsideration, Trial Institution
By Ben Baek* and Carl Kukkonen – On November 16, 2023, USPTO Director Kathi Vidal ordered a Delegated Rehearing Panel (“DRP”) to review whether the PTAB misapprehended or overlooked certain issues when denying challenger SynAffix B.V.’s petition for inter partes...
by Evan McLean | Nov 29, 2023 | Prior Art Issues, PTAB News, Trial Institution
By Evan Jones and Evan McLean – On September 21, 2023, the PTAB denied United Services Automobile Association’s petition to institute inter partes review of Auto Telematics’s U.S. Patent No. 9,633,487. IPR2023-00519, Paper 10. The ’487 patent relates generally...
by David Maiorana | Nov 21, 2023 | PTAB News, PTAB Trial Basics, Trial Institution
By David Linden and Dave Maiorana – On March 31, 2023, Zhuhai CosMX Battery Co., Ltd. (“Zhuhai”) filed a petition for inter partes review (“IPR”) of claims of U.S. Patent No. 11,329,352 (“the ’352 Patent”), assigned to Ningde Amperex Technology Ltd....
by Matthew Johnson | Nov 17, 2023 | Final Written Decisions, PTAB News, PTAB Trial Basics, Trial Institution
By Christian Roberts and Matthew Johnson – On October 6, 2023, the United States Patent and Trademark Office (“USPTO”) issued a Notice of Proposed Rulemaking (“NPR”) making changes to the Patent Trial and Appeal Board’s (“PTAB”) internal circulation and review...